使用覆膜支架主动脉分叉血管腔内重建技术治疗主髂动脉闭塞性疾病的长期结果:一项英国多中心研究
这项英国多中心回顾性研究纳入2012年11月1日至2020年3月31日期间接受覆膜支架主动脉分叉血管腔内重建(CERAB)的85例主髂动脉闭塞性疾病患者,随访至2024年3月。中位随访58.2个月,5年免于靶病变再干预率为83.0%,免于大截肢率各时间点均为98%,生存率80.1%。结论认为CERAB是耐久的血运重建选择,但复杂病变预后较差。
要点
- 中位随访58.2个月,5年免于靶病变再干预率83.0%,免于大截肢率各时间点均为98%。
- 髂动脉内膜下入路与较差的免于靶病变再干预率相关(HR 4.33)。
- 结论支持开展CERAB的随机对照试验,并关注TASC C和D病变复杂性的术前和术中决策。
核心结论
- CERAB治疗主髂动脉闭塞性疾病的长期结果证明其作为耐久血运重建选择的可行性,发病率、死亡率和通畅率可接受。
- 反映更复杂病变的因素与较差结果相关。
- 研究结果支持需要开展CERAB的随机对照试验,并关注基于TASC C和D病变复杂性的术前和术中决策。
研究设计与样本
- 英国多中心回顾性分析,纳入2012年11月1日至2020年3月31日期间接受CERAB的85例患者,随访至2024年3月。
- 通过术前影像评估解剖数据,结局指标包括免于靶病变再干预(fTLR)、免于大截肢(fMLA)和总生存率。
主要发现
- 中位年龄65岁,男性占62.4%。
- 中位随访58.2个月(IQR 55.7-67.1个月),2例失访。
- 整个研究期间死亡16例(18.8%),大截肢2例(2.4%)。
- 末次随访时14例(16.5%)需要靶病变再干预。
- Kaplan-Meier法1年、3年和5年fTLR分别为89.2%、83.0%和83.0%,fMLA各时间点均为98%,生存率分别为94.1%、89.4%和80.1%。
关键数值与推荐
- 髂动脉内膜下入路与较差的fTLR相关(HR 4.33,95%CI 1.30-14.37,p=0.017),调整患者和解剖特征后仍显著(HR 5.88,95%CI 1.02-33.95,p=0.047)。
- fTLR与索引术中需要股总动脉内膜切除术(HR 3.57,95%CI 0.42-30.5,p=0.244)或髂外动脉支架置入(HR 0.47,95%CI 0.07-3.05,p=0.427)无显著关联。
临床怎么用
- 研究结果支持CERAB作为开放手术的可行替代方案,尤其适用于复杂解剖或显著合并症的患者。
- 数据使临床医生能够在患者选择和手术策略方面做出更明智的决策,例如尽量减少髂动脉内膜下入路以改善长期结果。
- 研究强调需要进一步开展随机试验以确立CERAB在主髂动脉闭塞性疾病管理循证临床指南中的地位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This updated UK multicenter study aims to report long-term results following use of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) technique for treating aortoiliac occlusive disease (AIOD) in patients with chronic limb-threatening ischemia (CLTI) or intermittent claudication (IC). METHODS: A retrospective analysis was conducted including 85 patients who underwent CERAB between November 1, 2012, and March 31, 2020, till March 2024. Anatomical data were assessed using pre-operative imaging. Outcome measures included freedom from target lesion reintervention (fTLR), freedom from major limb amputation (fMLA), and overall survival. RESULTS: The median age was 65 years, with 62.4% males. Over a median follow-up of 58.2 months (IQR 55.7-67.1 months), 2 patients were lost to follow-up. There were 16 deaths (18.8%) and 2 major amputations (2.4%) in the entire study period. Target lesion reintervention was required in 14 patients (16.5%) at the last follow-up. The Kaplan-Meier fTLR at 1, 3, and 5 years was 89.2%, 83.0%, and 83.0%, respectively. fMLA at 1, 3, and 5 years was 98% at all intervals, and survival rates at 1, 3, and 5 years were 94.1%, 89.4%, and 80.1%, respectively. Subintimal iliac access was associated with worse fTLR (HR 4.33 (95% CI 1.30-14.37, p=0.017)), which remained significant when adjusted to patient and anatomical characteristics (HR 5.88 (95% CI 1.02-33.95, p=0.047)). There was no significant association between fTLR and the need for common femoral endarterectomy (HR 3.57 (95% CI 0.42-30.5, p=0.244)] or external iliac artery stenting (HR 0.47 (95% CI 0.07-3.05, p=0.427)) during the index procedure. CONCLUSION: The long-term outcomes of CERAB for treating AIOD demonstrate its viability as a durable revascularization option, with acceptable morbidity, mortality, and patency rates. Factors reflecting more complex lesions are associated with poorer outcomes. Findings support the need for randomized controlled trials on CERAB and a focus on the pre- and intra-operative decision-making based on the complexity of TASC C and D lesions.Clinical ImpactThe findings of this study reinforce the long-term durability of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) technique for treating aortoiliac occlusive disease (AIOD), demonstrating favourable reintervention and limb salvage rates. These results support CERAB as a viable alternative to open surgery, particularly in patients with complex anatomies or significant comorbidities. This data enables clinicians to make more informed decisions regarding patient selection and procedural strategies, such as minimising the use of subintimal iliac access to improve long-term outcomes. The study underscores the need for further randomised trials to establish CERAB's role in evidence-based clinical guidelines for AIOD management.
引用
- Wafi A, Saratzis A, Abisi S, et al. Long-Term Results of Treatment of Aortoiliac Occlusive Disease With the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique: A UK Multicenter Study. J Endovasc Ther. 2025. PMID: 39902659. doi:10.1177/15266028251314695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。